Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TALK · against 1,336 other Healthcare companies
Ranked #903 of 1,337 · scores higher than 32% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including TALK · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | TALK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -0.2% | 1.5% | 40% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 1.0% | 4.2% | 35% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 0.5% | -1.0% | 55% | 20% | |
| Book yieldHigher is better · 1,306 reported | 12.9% | 37.9% | 18% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 903 | 8.9B USD | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 51 |
| 903 | 1.1B USD | 32 | 61 |
| 903 | 1.9B NZD (≈$1.1B) | 32 | 42 |
| 903 | 1.5B EUR (≈$1.6B) | 32 | 44 |
| 903 | 871M USD | 32 | 53 |
| 903 | 3.0B CHF (≈$3.5B) | 32 | 33 |
| 917 | 3.0B CNY (≈$419M) | 31 | 49 |
| 917 | 2.3B CNY (≈$323M) | 31 | 40 |
| 917 | 2.2B USD | 31 | 36 |